Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid.Sandrine Théoleyre,Ingrid Masson,Guillaume Herbreteau,Audrey Vallée,Hélène Sénellart,Marc G DenisLung Cancer(2017)引用 6|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要